Her2 Blockade: Top KOLs in the world
 #1 | Jose M Baselga |
Memorial Sloan Kettering Cancer Center, New York, NY. | Astr | star star star star star | | Known for Monoclonal Antibodies | Advanced Solid Tumors | Postmenopausal Women | Growth Factor | Breast Cancer |
|
#2 | Javier Cortés |
From the International Breast Cancer Center, Quirónsalud Gro | star star star star star | | Known for Advisory Consultancy | Etirinotecan Pegol | Phase Iii | Brain Metastases | Breast Cancer |
|
Click on a star to see more details touch_app
#3 | Graham A Ross |
F. Hoffmann-La Roche Ltd., Basel, Switzerland; | AstraZeneca | star star star star star_half | | Known for Pertuzumab Trastuzumab | Cell Lung | Breast Cancer | Phase Iii | Oral Topotecan |
|
#4 | Vladimir Fedorovich Semiglazov |
NN Petrov Research Inst of Oncology, St. Petersburg, Russian | star star star star star_half | | Known for Estrogen Receptors | Neoadjuvant Chemotherapy | Pathological Complete Response | Phase Iii | Breast Cancer |
|
#5 | Seock Ah Im |
Cancer Research Institute, Seoul National University, Seoul, | star star star star star_border | | Known for Neoadjuvant Chemotherapy | Advisory Consultancy | Grant Funding | Premenopausal Women | Breast Cancer |
|
#6 | Sandra Meta Swain |
Georgetown University Medical Center, Washington, WA; | Geor | star star star star star_border | | Known for Adjuvant Chemotherapy | Pertuzumab Trastuzumab | Nrg Oncology | Monoclonal Antibodies | Breast Cancer |
|
#7 | Tadeusz Pienkowski |
Postgraduate Medical Education Center. | Postgraduate Medica | star star star star star_border | | Known for Trastuzumab Docetaxel | 5 Years | Phase Iii | Estrogen Receptors | Breast Cancer |
|
#8 | Luca Gianni |
Fondazione Michelangelo, Milan, Italy | Gianni Bonadonna Fou | star star star star star_border | | Known for 1 Year | Monoclonal Antibodies | Trastuzumab Emtansine | Pathological Complete Response | Breast Cancer |
|
#9 | Young‐Hyuck Im |
Medicine Dept., Hematology/Medical Oncology Division, Samsun | star star star star star_border | | Known for Neoadjuvant Chemotherapy | Endocrine Therapy | Grant Funding | Brain Metastasis | Breast Cancer |
|
#10 | Dennis J Slamon |
David Geffen School of Medicine at UCLA, Los Angeles, CA; | | star star star star star_border | | Known for Monoclonal Antibodies | Situ Hybridization | Cell Lines | Her2 Neu | Breast Cancer |
|
